ATL-DC vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ATL-DC vaccine, covering 2025-08-22 to 2025-08-22. Get the full timeline:
Most recent: Clinical Trial Update: Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma [Phase 1]